Spasticity Market : Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Osmotica Pharmaceuticals, Revance Therapeutics, Bionorica SE and Others.

July 07 22:10 2021
Spasticity Market : Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Osmotica Pharmaceuticals, Revance Therapeutics, Bionorica SE and Others.

Spasticity Market

Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.


DelveInsight’s “ Spasticity Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some Key Highlights from the Spasticity Market Report:

  • In the US, about 764,000 children and adults currently have Cerebral Palsy and around 500,000 children under age of 18 currently have Cerebral Palsy.
  • In UK the prevalence of CP is 186 per 100,000 population, such that a total of 110,000 people are affected.
  • Spasticity affects approximately 35% of those with stroke, more than 90% with CP, about 50% of Traumatic brain injury (TBI) patients, 40% of SCI patients, and between 37% and 78% of MS patients.
  • According to DelveInsight’s analysis, Children are affected more with Spasticity as compared to adult.
  • United States has the highest percentage of Prevalent diagnosed & treated patients


To gain more insights request sample @


Spasticity is the most commonly reported symptom for Multiple sclerosis, seen in 90% of patients. Most cases of spasticity can be subdivided into spinal or cerebral spasticity. Spinal spasticity results from the removal or destruction of supraspinal control and leads to increased excitability of motor neurons, whereas cerebral spasticity stems from a loss of descending inhibition.

The American Association of Neurological Surgeons estimated that spasticity affects more than 12 million people worldwide.


To gain more insights request sample @


Some of the Spasticity Companies:

  • Osmotica Pharmaceuticals,
  • Revance Therapeutics
  • Bionorica SE
  • Merz Pharmaceuticals
  • GW Pharmaceuticals Ltd.
  • And Many Others


Spasticity Pipeline Therapies:

  • Arbaclofen ER
  • DAXI
  • BX-1
  • And Many Others


To gain more insights request sample @


Table of Contents


Report Introduction


Executive Summary of Spasticity


Spasticity Market Overview at a Glance


Disease Background and Overview: Spasticity


Case Reports of Spasticity


Spasticity Patient Journey


Spasticity Epidemiology and Patient Population


Epidemiology of Spasticity by Countries (2018–2030)


Spasticity Treatments and Medical Practices


Spasticity Marketed Therapies


Spasticity Emerging Therapies 


Spasticity Market Size


7MM: Country-wise Market Analysis


Spasticity Market Drivers


Spasticity Market Barriers


SWOT Analysis


KOL Views


Reimbursement and market access


Report Methodology


DelveInsight Capabilities




About DelveInsight


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States